Company profile
SMi Drug Discovery
Smi Drug Discovery Limited is a UK company with status active founded in 2018 based in East of England.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNzcwNzYwNGFkaXF6a2N4
Published 30 Sep 2024 10:21
RESOLUTIONS | Transaction WURCQzRIWFRhZGlxemtjeA | Paper/PDF filed
Published 14 Sep 2024 06:59
SH01 | Transaction MzQzNTUwMTI2OWFkaXF6a2N4
Published 12 Sep 2024 14:31
SH01 | Transaction MzQzMjE3ODMyN2FkaXF6a2N4
Published 14 Aug 2024 16:54
Company registered at Companies House
1 Dec 2022 to 31 Jul 2024
SMi is developing a new technology that analyses patient samples by directly visualising the single molecules that are responsible for different diseases. Using this approach SMi applies a patient sample to the surface of its consumable diagnostic chips and places these chips inside a specialised, benchtop, super-resolution microscope that can scan a larg...
1 Aug 2021 to 31 Jan 2023
SMi Drug Discovery, a developer of optical devices capable of unprecedented levels of resolution, has designed an automated diagnostic device that will enable the detection of both past and present COVID-19 infections. Unlike other tests, SMi's technology directly observes single molecules to provide irrefutable evidence of their existence. The device pro...
